| Literature DB >> 1279173 |
W S Saari1, J S Wai, T E Fisher, C M Thomas, J M Hoffman, C S Rooney, A M Smith, J H Jones, D L Bamberger, M E Goldman.
Abstract
A series of nonnucleoside 3-aminopyridin-2(1H)-one derivatives was synthesized and evaluated for HIV-1 RT inhibitory properties. Several analogs proved to be potent and highly selective antagonists with in vitro IC50 values as low as 19 nM in the enzyme assay using rC.dG as template-primer. Two compounds from this series, 3-[[(4,7-dimethylbenzoxazol-2-yl)methyl]-amino]-5-ethyl-6-methy lpyridin-2(1H)-one (34, L-697,639) and the corresponding 4,7-dichloro analogue (37, L-697,661) inhibited the spread of HIV-1 IIIb infection by 95% in MT4 cell culture at concentrations of 25-50 nM and were selected for clinical trials as antiviral agents.Entities:
Mesh:
Substances:
Year: 1992 PMID: 1279173 DOI: 10.1021/jm00099a007
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446